INFORM Archives/News

INFORM Archives/News2024-06-18T11:50:25-04:00

Ultragenyx Announces U.S. FDA Approval of Dojolvi™ (UX007/triheptanoin), the First FDA-Approved Therapy for the Treatment of Long-chain Fatty Acid Oxidation Disorders

By |February 13th, 2023|Categories: INFORM News|Tags: , , , |

Ultragenyx Announces U.S. FDA Approval of Dojolvi™ (UX007/triheptanoin), the [...]

Efficacy of a Diet Supplemented With Triheptanoin Proven Greater Than IMB-203 in Treating VLCAD Deficiency

By |September 23rd, 2022|Categories: INFORM News, VLCAD Deficiency|Tags: , , , |

Efficacy of a Diet Supplemented With Triheptanoin Proven Greater [...]

Ultragenyx CEO and Founder Discusses Fundamental Flaws in Drug Development Process

By |September 9th, 2022|Categories: INFORM News|Tags: , , |

Ultragenyx CEO and Founder Discusses Fundamental Flaws in Drug [...]

Unlocking the Future

We are committed to discovering new FAOD treatments and cures to improve the lives of our patients and their families.

Go to Top